Inflammation in CNS neurodegenerative diseases
Predictions For 2023 And Beyond As our analysis demonstrates, in FY2022 COVID-19 remained an issue for FDA, although the agency has shown signs that it is shifting toward regular business for example, circling back on repeat offenses, holding firms accountable up and down drug supply chains, and enforcing against non-COVID-19 related products, such as skin bleaching agents
Similar to insulin resistance, some patients may develop resistance or diminished sensitivity to GLP-1 effects over time
Contact your GP, study team, or supervising clinician if fatigue: Is severe enough to significantly impair daily functioning, work, or personal care Persists without any improvement despite the dose stabilising Is accompanied by dizziness, fainting, or palpitations , which may suggest dehydration or electrolyte disturbance Occurs alongside unexplained weight loss beyond expected levels , pallor, or breathlessness which could indicate nutritional anaemia Is associated with low mood, persistent sadness, or loss of motivation , as these may suggest depression rather than drug-related tiredness Develops alongside jaundice, dark urine, or abdominal pain , which warrant urgent assessment to exclude hepatic or pancreatic causes Seek urgent medical attention (call 999 or go to A&E) if you experience: Severe, persistent upper abdominal pain, particularly if it radiates to the back and is accompanied by vomiting these are potential symptoms of pancreatitis and require immediate assessment [12] Chest pain, severe dizziness, confusion, or an inability to keep any fluids down For urgent advice that does not require emergency services , contact NHS 111 (online at 111.nhs.uk or by telephone)
